The European Medicines Agency (EMA) is seeking feedback on its approach to the labeling of advanced therapy medicinal products (ATMPs) that contain genetically modified cells. In the draft guideline, ...
This content is provided by RegLink News, publishers of e-weekly global regulatory news. RegLink offers a 30-day free trial and 15% discount on Global Update subscriptions to RAPS members. German ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results